Medicine information
Uses & overview
APIXAZEN 2.5 is an oral anticoagulant formulation from Steris Healthcare containing Apixaban 2.5 mg per tablet. Apixaban is a direct factor Xa inhibitor that helps reduce blood clot formation by acting on an important component of the body's coagulation process. Product Details Brand Name: APIXAZEN 2.5 Composition: Apixaban 2.5 mg Dosage Form: Tablets Therapeutic Category: Oral Anticoagulant Drug Class: Direct Factor Xa Inhibitor Company Name: Steris Healthcare How APIXAZEN 2.5 Works Apixaban selectively inhibits factor Xa, a protein involved in the production of thrombin during blood clotting. By reducing factor Xa activity, it helps prevent the formation and growth of harmful blood clots. Uses of APIXAZEN 2.5 Tablets Depending on the approved product labeling and the patient's clinical condition, Apixaban 2.5 mg may be prescribed for: Reducing the risk of stroke and systemic embolism in eligible patients with non-valvular atrial fibrillation when the reduced dose is appropriate. Preventing venous thromboembolism following certain hip or knee replacement surgeries. Preventing recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) after initial treatment, when the reduced dose is appropriate. The appropriate dose depends on the condition being treated, the stage of treatment, age, kidney function, other medicines, and bleeding risk. Apixaban 2.5 mg is not interchangeable with the 5 mg strength for every indication. The dose must be selected by a qualified healthcare professional.
How to use
APIXAZEN 2.5 is an oral anticoagulant formulation from Steris Healthcare containing Apixaban 2.5 mg per tablet. Apixaban is a direct factor Xa inhibitor that helps reduce blood clot formation by acting on an important component of the body's coagulation process. Product Details Brand Name: APIXAZEN 2.5 Composition: Apixaban 2.5 mg Dosage Form: Tablets Therapeutic Category: Oral Anticoagulant Drug Class: Direct Factor Xa Inhibitor Company Name: Steris Healthcare How APIXAZEN 2.5 Works Apixaban selectively inhibits factor Xa, a protein involved in the production of thrombin during blood clotting. By reducing factor Xa activity, it helps prevent the formation and growth of harmful blood clots. Uses of APIXAZEN 2.5 Tablets Depending on the approved product labeling and the patient's clinical condition, Apixaban 2.5 mg may be prescribed for: Reducing the risk of stroke and systemic embolism in eligible patients with non-valvular atrial fibrillation when the reduced dose is appropriate. Preventing venous thromboembolism following certain hip or knee replacement surgeries. Preventing recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) after initial treatment, when the reduced dose is appropriate. The appropriate dose depends on the condition being treated, the stage of treatment, age, kidney function, other medicines, and bleeding risk. Apixaban 2.5 mg is not interchangeable with the 5 mg strength for every indication. The dose must be selected by a qualified healthcare professional.
